1. Du, Hongzhi, Pang, Mao, Hou, Xiaoying, Yuan, Shengtao, Sun, Li. 2017. PLOD2 in cancer research. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 90, 670-676. doi:10.1016/j.biopha.2017.04.023. https://pubmed.ncbi.nlm.nih.gov/28415047/
2. Wang, Zhen, Fan, Gentao, Zhu, Hao, Zhao, Jianning, Zhou, Guangxin. 2022. PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma. In Frontiers in oncology, 12, 980390. doi:10.3389/fonc.2022.980390. https://pubmed.ncbi.nlm.nih.gov/36276118/
3. Gjaltema, Rutger A F, Goubert, Désirée, Huisman, Christian, Bank, Ruud A, Rots, Marianne G. 2020. KRAB-Induced Heterochromatin Effectively Silences PLOD2 Gene Expression in Somatic Cells and is Resilient to TGFβ1 Activation. In International journal of molecular sciences, 21, . doi:10.3390/ijms21103634. https://pubmed.ncbi.nlm.nih.gov/32455614/
4. Li, Huan, Zhao, Jun, Deng, Hao, Liu, Honghai, Zhang, Xinzong. 2023. N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele. In Cellular & molecular biology letters, 28, 72. doi:10.1186/s11658-023-00475-4. https://pubmed.ncbi.nlm.nih.gov/37670228/
5. Chen, Yimeng, He, Yichen, Li, Zhengsheng, He, Xiaozhou, Xue, Dong. 2024. METTL3 facilitates renal cell carcinoma progression by PLOD2 m6A-methylation under prolonged hypoxia. In Cell death & disease, 15, 62. doi:10.1038/s41419-023-06411-w. https://pubmed.ncbi.nlm.nih.gov/38233403/
6. Li, Keren, Niu, Yi, Li, Kai, Yuan, Yunfei, Li, Binkui. 2023. Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. In Journal of clinical and translational hepatology, 11, 1094-1105. doi:10.14218/JCTH.2022.00401. https://pubmed.ncbi.nlm.nih.gov/37577214/
智鼠故事 
